Reductions in positive Clostridioides difficile events reportable to National Healthcare Safety Network (NHSN) with adoption of reflex enzyme immunoassay (EIA) testing in 13 Atlanta hospitals

Infect Control Hosp Epidemiol. 2022 Jul;43(7):935-938. doi: 10.1017/ice.2021.145. Epub 2021 Jul 8.

Abstract

In total, 13 facilities changed C. difficile testing to reflexive testing by enzyme immunoassay (EIA) only after a positive nucleic acid-amplification test (NAAT); the standardized infection ratio (SIR) decreased by 46% (range, -12% to -71% per hospital). Changing testing practice greatly influenced a performance metric without changing C. difficile infection prevention practice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacterial Toxins*
  • Clostridioides
  • Clostridioides difficile*
  • Clostridium Infections*
  • Delivery of Health Care
  • Hospitals
  • Humans
  • Immunoenzyme Techniques
  • Reflex

Substances

  • Bacterial Toxins